In recent decades, there has been great progress in the diagnosis of BC, but only oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor2 (Her2) are typically used for BC diagnosis in routine clinical practice. This evidence concerns the gene PGR and breast cancer.